...
首页> 外文期刊>Gait & posture >Quantifying gait impairment in multiple sclerosis using GAITRite technology.
【24h】

Quantifying gait impairment in multiple sclerosis using GAITRite technology.

机译:使用GAITRite技术量化多发性硬化症的步态障碍。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This pilot study investigated the validity of the functional ambulatory profile (FAP) score from the GAITRite electronic pathway in persons with multiple sclerosis (PwMS) who had onset of walking impairment. Thirteen PwMS who had Expanded Disability Status Scale (EDSS) scores of 4.0-6.0 performed four trials on GAITRite pathway, and completed a multidimensional walking assessment including performance tests (timed 25 foot walk; T25FW, timed up and go; TUG), self reports of walking ability (Multiple Sclerosis Walking Scale-12; MSWS-12) and function (Late Life Function and Disability Inventory; LL-FDI), and free-living walking behavior (accelerometry). The FAP score correlated strongly with neurological disability (EDSS, rho=-0.81), walking performance (T25FW, rho=-0.82; TUG, rho=-0.88) and self-reported walking function (LL-FDI, rho=0.81), and moderately with self-reported walking impairment (MSWS-12, rho=0.49) and free-living walking behavior (accelerometry, rho=0.52). This suggests that the FAP score is a valid marker of gait impairment in PwMS who have onset of walking impairment.
机译:这项前瞻性研究调查了GAITRite电子途径对行走障碍发作的多发性硬化症(PwMS)患者的动态门诊动态(FAP)评分的有效性。十三名PwMS的扩展残疾状况量表(EDSS)评分为4.0-6.0,并在GAITRite途径上进行了四项试验,并完成了包括性能测试(定时25英尺步行; T25FW,定时走; TUG),自我报告的多维步行评估步行能力(多发性硬化步行量表12; MSWS-12)和功能(晚期生活功能和残疾量表; LL-FDI)以及自由活动步行行为(加速度计)的信息。 FAP评分与神经功能障碍(EDSS,rho = -0.81),步行表现(T25FW,rho = -0.82; TUG,rho = -0.88)和自我报告的步行功能(LL-FDI,rho = 0.81)密切相关,中度有自我报告的步行障碍(MSWS-12,rho = 0.49)和自由活动的步行行为(加速度计,rho = 0.52)。这表明FAP评分是患有步行障碍的PwMS步态障碍的有效标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号